MF
MFGenie.ai
Sectoral / Thematicregulargrowth📊 BSE Healthcare

Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth

Aditya Birla Sun Life Mutual Fund

#25 of 213 (1Y)

₹33.0400

0.43 (-1.28%)

NAV as of 29 May 2026

Today's NAV — all variants

Regular · Growth

₹₹33.0400

0.43 (-1.28%)

29 May 2026

AMFI: 147407

Direct · Growth

₹₹36.7000

0.47 (-1.26%)

29 May 2026

AMFI: 147409

Regular · IDCW

₹₹21.8200

0.28 (-1.27%)

29 May 2026

AMFI: 147408

Direct · IDCW

₹₹23.8600

0.31 (-1.28%)

29 May 2026

AMFI: 147410

Returns (Lumpsum)

CAGR for periods ≥ 1 year
1 Week+0.66%
1 Month+8.36%
3 Months+9.24%
6 Months+6.57%
1 Year+12.81%
3 Years (CAGR)+25.79%
5 Years (CAGR)+13.02%
10 Years (CAGR)
Since Inception (Jun 2019)+19.15%

SIP Returns (XIRR)

₹1,000/month SIP, annualised
1 Year SIP+17.82%
3 Year SIP+15.85%
5 Year SIP+16.40%
Since Inception (Jun 2019)+17.40%

SIP since inception — what ₹100/month became

Real NAV backtest from day one

₹8,200

Invested

₹14,647

Value today

16.7%

XIRR (p.a.)

100/month SIP from fund inception · Current value as of today

Try SIP Calculator with this fund's history

1,000 lumpsum at launch — value today

Invested on the fund's first NAV date

₹1,000

Invested

₹3,304

Value today

19.0%

CAGR (p.a.)

One-time investment at fund inception · Growth purely from NAV appreciation

Try Lumpsum Calculator

₹10L corpus with ₹5,000/month withdrawals since inception

Corpus is still growing despite monthly payouts

₹10,00,000

Initial corpus

₹4,10,000

Withdrawn

₹25,71,632

Corpus left

+₹19,81,632 net gain — withdrew ₹4,10,000 AND corpus grew

Plan your SWP with real NAV

₹6L corpus via 12-month STP from a liquid fund at inception

₹50K/month transferred from HDFC Liquid → this fund at launch

₹6,00,000

Invested

₹18,79,187

Value today

-5.2%

vs lumpsum

Direct lumpsum would have beaten STP by 5.2% — but STP reduced timing risk

Model your own STP with real NAV

Beat the benchmark — ₹100/month SIP

Same SIP in this fund vs the benchmark index

This fund

₹14,647

Benchmark

₹13,324

+₹1,323 extra wealth vs the benchmark index

Backtest this SIP yourself

₹1 lakh on the worst crash day — 22 Mar 2020

Worst single-day Nifty drop during this fund's life

₹1,00,000

Invested

₹3,56,034

Value today

3.6×

Multiple

Staying invested through that crash turned ₹1L into ₹3,56,034 — a 3.6× return

Read: Staying invested through crashes

Direct vs Regular — ₹500/month over 6 years

Expense ratio drag on your actual returns

Direct plan

₹61,993

Regular plan

₹59,002

Direct earns ₹2,991 more on a ₹36K investment1.38% extra return per year

Same fund, same NAV history — only the expense ratio differs. Direct plans always outperform Regular over time.

Learn about Direct vs Regular plans

Fund Details

Fund HouseAditya Birla Sun Life Mutual Fund
CategorySectoral / Thematic
Plan Typeregular
Optiongrowth
AUM₹843 Cr
Expense Ratio2.30%
Min SIP₹100
Min Lumpsum₹1,000
BenchmarkBSE Healthcare ✓
Launch Date20 Jun 2019
AMFI Code147407

Risk Metrics

Trailing 1 year, annualised

0.03

Sharpe Ratio

+0.04

Alpha

0.31

Beta

0.02

Sortino

13.90%

Std Dev

-15.31%

Max Drawdown

Portfolio Holdings

Top 50 holdings · as of Mar 2026

Security% NAV

Sun Pharmaceutical Industries Limited

INE044A01036

13.42%

Sun Pharmaceutical Industries Limited

INE044A01036

13.17%

Apollo Hospitals Enterprise Limited

INE437A01024

7.34%

Apollo Hospitals Enterprise Limited

INE437A01024

7.20%

Torrent Pharmaceuticals Limited

INE685A01028

5.03%

J.B. Chemicals & Pharmaceuticals Limited

INE572A01036

4.99%

Torrent Pharmaceuticals Limited

INE685A01028

4.76%

J.B. Chemicals & Pharmaceuticals Limited

INE572A01036

4.71%

Aurobindo Pharma Limited

INE406A01037

4.49%

Aurobindo Pharma Limited

INE406A01037

4.42%

Ajanta Pharmaceuticals Limited

INE031B01049

4.22%

Lupin Limited

INE326A01037

4.21%

IPCA Laboratories Limited

INE571A01038

4.11%

Ajanta Pharmaceuticals Limited

INE031B01049

4.05%

Lupin Limited

INE326A01037

4.00%

Abbott India Limited

INE358A01014

3.90%

Mankind Pharma Ltd

INE634S01028

3.88%

Fortis Healthcare Limited

INE061F01013

3.87%

Abbott India Limited

INE358A01014

3.65%

Fortis Healthcare Limited

INE061F01013

3.49%

Emcure Pharmaceuticals Ltd

INE168P01015

3.32%

Emcure Pharmaceuticals Ltd

INE168P01015

3.30%

Cipla Limited

INE059A01026

3.30%

Cipla Limited

INE059A01026

3.24%

Mankind Pharma Ltd

INE634S01028

2.93%

IPCA Laboratories Limited

INE571A01038

2.86%

Shilpa Medicare Ltd

INE790G01031

2.51%

Shilpa Medicare Ltd

INE790G01031

2.26%

CORONA Remedies Ltd

INE02ZQ01018

2.24%

SAI Life Sciences Ltd

INE570L01029

2.20%

Alkem Laboratories Limited

INE540L01014

2.16%

CORONA Remedies Ltd

INE02ZQ01018

2.12%

Alkem Laboratories Limited

INE540L01014

2.10%

SAI Life Sciences Ltd

INE570L01029

2.09%

Procter & Gamble Health Limited

INE199A01012

2.04%

Procter & Gamble Health Limited

INE199A01012

1.97%

Jupiter Life Line Hospitals Ltd

INE682M01012

1.96%

Divi's Laboratories Limited

INE361B01024

1.88%

Divi's Laboratories Limited

INE361B01024

1.80%

Jupiter Life Line Hospitals Ltd

INE682M01012

1.79%

SANOFI CONSUMER HEALTHCARE

INE0UOS01011

1.67%

SANOFI CONSUMER HEALTHCARE

INE0UOS01011

1.58%

Thyrocare Technologies Limited

INE594H01019

1.58%

Dr. Reddys Laboratories Limited

INE089A01031

1.45%

Dr. Reddys Laboratories Limited

INE089A01031

1.45%

Thyrocare Technologies Limited

INE594H01019

1.44%

METROPOLIS HEALTHCARE LIMITED

INE112L01020

1.42%

Pfizer Limited

INE182A01018

1.40%

METROPOLIS HEALTHCARE LIMITED

INE112L01020

1.36%

ALEMBIC PHARMACEUTICALS LIMITED

INE901L01018

1.35%

Performance Comparison

Interested in This Fund?

Our experts will help you decide if this fund fits your goals.

+91

By submitting, you agree to our Privacy Policy. No spam, ever.

Investment Objective

Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.

About This Fund

Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth is a Sectoral / Thematic mutual fund offered by Aditya Birla Sun Life Mutual Fund. The fund has been operational for over 6 years. It manages assets worth ₹843 Cr, reflecting investor confidence in the fund's strategy. It benchmarks its performance against BSE Healthcare. The current expense ratio is 2.30%.

Who Should Invest?

  • Investors with a high risk appetite seeking long-term wealth creation
  • Investors with an investment horizon of 5 years or more
  • SIP investors who can benefit from rupee cost averaging during market fluctuations